Vale, CL;
Burdett, S;
Rydzewska, LH;
Albiges, L;
Clarke, NW;
Fisher, D;
Fizazi, K;
... Tierney, JF; + view all
(2016)
Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data.
The Lancet Oncology
, 17
(2)
pp. 243-256.
10.1016/S1470-2045(15)00489-1.